Could Halving Clinical Trial Costs Double the Benefits of Clinical Research?
Clinical trials are essential for developing new therapies, but they are also widely known to be expensive. Conducting a single clinical study often requires large budgets, complex coordination, and significant operational infrastructure.
But this raises an important question: How much of the cost of clinical trials is driven by scientific requirements—and how much is driven by operational complexity?
Clinical trials must support patient care, medical procedures, and the evaluation of investigational treatments. These elements are essential and cannot be eliminated. However, a substantial portion of clinical trial budgets is also devoted to coordinating processes, documenting activities, reconciling information across systems, and managing regulatory workflows.
In this sense, clinical trials are not only scientific investigations. They are also large operational systems.
Understanding how these systems are organized may reveal opportunities to improve efficiency without compromising scientific quality.
Some observations about operational inefficiency
Several structural patterns appear frequently in modern clinical trial operations.
-
If information must be entered into multiple systems, the cost of producing that information multiplies. Clinical trials commonly rely on multiple platforms such as CTMS, EDC, IRT, and eTMF, each responsible for different operational functions.
-
When systems do not integrate naturally, organizations spend resources reconciling information between them. A large share of operational work becomes the process of verifying that different systems agree with each other.
-
Many operational costs arise not from generating data, but from aligning fragmented workflows.
-
Monitoring and verification activities represent a substantial share of trial costs. Source Data Verification alone has been estimated to account for 25–40% of monitoring effort in some studies.
-
Operational complexity often grows faster than scientific complexity. Over time, additional systems and processes are introduced to meet new requirements, while the overall workflow remains largely unchanged.
-
Every additional system introduces coordination and reconciliation costs. Separate platforms, spreadsheets, and communication channels create layers of operational overhead.
Taken together, these patterns suggest that a significant share of clinical trial effort is devoted not to scientific discovery, but to managing fragmented operational processes.
If duplication and reconciliation could be reduced, the overall operational burden might decrease significantly.
Understanding the structure of clinical trial budgets
Clinical trial budgets typically consist of three main components.
Sponsor or CRO operational fees: These include the activities required to manage and coordinate the study:project management, monitoring, data management, regulatory coordination, statistical analysis
Operational management often represents a significant share of total trial cost, especially in multi-site studies.
Pass-through costs: Pass-through costs are external expenses that sponsors pay for services required by the study.
Examples include:
-
laboratory tests
-
imaging procedures such as MRI or CT
-
central laboratory services
-
drug logistics and supply
-
patient recruitment services
These costs depend largely on protocol design and trial complexity.
They typically cover:
-
investigator and study coordinator time
-
patient visit management
-
regulatory documentation
-
site infrastructure and overhead
These costs vary widely depending on therapeutic area, geography, and study design.
Can all costs be optimized?
Not all clinical trial costs can be reduced.
Medical procedures, investigational products, and patient care are essential elements of clinical research.
However, the operational architecture of clinical trials strongly influences how efficiently these activities are coordinated.
Well-designed studies can optimize:
-
monitoring strategies
-
protocol complexity
-
site workflows
-
system integration
-
documentation processes
When trial operations are carefully structured, improvements may influence all three cost categories—fees, pass-through costs, and investigator grants.
Why the idea of “half the cost” appears
The idea that clinical trial costs could potentially be reduced by half should not be interpreted as a precise prediction.
Instead, it reflects a structural observation:
When operational systems contain duplication and parallel workflows, removing redundant steps can dramatically reduce total effort.
If operational processes require the same information to be entered, verified, and documented multiple times, organizations effectively pay for the same work repeatedly.
Reducing duplication does not simply reduce software costs. It also reduces the labor required to manage parallel workflows.
In many industries, eliminating redundant operational processes has produced efficiency improvements of one-third to one-half of total effort.
Clinical trials may contain similar opportunities, particularly in areas such as:
-
manual documentation
-
system reconciliation
-
monitoring administration
-
operational coordination
Why this question matters?
If clinical trial costs could be significantly reduced, even by one-third or one-half in some cases, the implications would extend far beyond operational efficiency.
Lower costs could allow research organizations to conduct more studies and explore more scientific hypotheses, increasing the likelihood of important discoveries.
Operational improvements could also reduce the administrative burden placed on clinical research professionals. By decreasing repetitive manual tasks and system reconciliation work, teams could focus more on scientific thinking, patient care, and study design.
This shift may also help address a persistent challenge in clinical research: workforce fatigue and administrative overload.
More efficient operational systems could therefore support:
-
more clinical studies conducted with the same resources
-
faster testing of new therapeutic hypotheses
-
reduced administrative burden on research staff
-
greater focus on scientific and clinical decision-making
-
broader participation of smaller institutions and academic groups in research
Ultimately, improving the operational architecture of clinical trials is not only about reducing cost.
It is about freeing scientific capacity.
If clinical trial costs could be substantially reduced, the same research budgets might support twice the research activity, leading to more discoveries, more treatments, and healthier patients.
